Zinzino's Q1 Financial Performance
Swedish direct sales company Zinzino AB (publ) has reported a significant revenue increase of 26% in the first quarter of 2026 compared to the same period last year. The total revenue for Q1 2026 reached approximately SEK 915.4 million (around USD $97 million), up from SEK 723.7 million in Q1 2025.
Performance Breakdown
In March 2026 alone, Zinzino's revenue from its sales markets surged by 29%, totaling SEK 342.2 million (approximately USD $36.3 million), compared to SEK 265.8 million in March 2025. This robust growth indicates a strong demand for Zinzino's products, particularly in the areas of personalized nutrition and scientific skincare.
However, it is important to note that Faun Pharma, one of the company’s subsidiaries, experienced a decline in external sales, reporting SEK 6.6 million in Q1, down from SEK 7.1 million the previous year. Despite this setback, the overall group revenue remained positively impacted, achieving a total of SEK 348.8 million for the month, up from SEK 272.9 million in March 2025.
Company Overview
Zinzino AB operates as a global direct-sales entity focused on health and wellness products. The company specializes in test-based, personalized nutrition and scientific skincare solutions. It is publicly traded on the Nasdaq First North Premier Growth Market, further enhancing its visibility and credibility in the industry.
With products available in over 100 markets worldwide, Zinzino has expanded its portfolio through strategic acquisitions, including health and wellness brands such as It Works!, Enhanzz Global, Truvy, and several others. Additionally, Zinzino co-owns the olive oil producer Cleanthi Alpha-Olenic LTD and owns the Swiss biotech skincare brand HANZZ+HEIDII. The company’s headquarters are located in Gothenburg, Sweden, with additional offices across Europe, Asia, and Australia.
Industry Implications
The 26% revenue growth reported by Zinzino is indicative of a broader trend in the direct sales and MLM industry, where consumer interest in health and wellness products continues to rise. The ability of Zinzino to maintain growth, even amid challenges faced by certain subsidiaries, underscores the resilience of its business model and product offerings.
As competition in the MLM sector intensifies, companies that effectively leverage scientific validation of their products, alongside a robust distribution network, are likely to thrive. Zinzino's performance could serve as a benchmark for other companies in the industry, especially those seeking to enhance their product lines and market reach.
For further information about Zinzino and its offerings, visit www.zinzino.com.
